A novel <i>in vitro</i> approach for embryo-fetal risk assessment using human iPS cells
-
- KIMURA Maya
- Takeda Pharmaceutical Company Limited
-
- MIYAWAKI Akimitsu
- Takeda Pharmaceutical Company Limited
-
- IZUMI Yuko
- Takeda Pharmaceutical Company Limited
-
- MATSUMOTO Kiyoshi
- Takeda Pharmaceutical Company Limited
-
- SHINOZAWA Tadahiro
- Takeda Pharmaceutical Company Limited
Bibliographic Information
- Other Title
-
- 医薬品の発生毒性リスク評価のためのヒトiPS細胞を用いた<i>in vitro</i>評価系の構築
Description
<p>In drug development, embryo-fetal risk assessment is critical to ensure safety in patients. Recently, the modality of drugs has been diversified to antibody, nucleic acids, and gene therapy; while species differences in epitopes or nucleic acid sequences limit the appropriate safety evaluations in animals. In this presentation, a convenient approach to evaluate human-specific embryo-fetal risks in vitro using human iPS cells will be introduced. Also, current in vitro systems for evaluation of embryo-fetal risk will be summarized and the usefulness of human-specific systems will be discussed.</p>
Journal
-
- Annual Meeting of the Japanese Society of Toxicology
-
Annual Meeting of the Japanese Society of Toxicology 47.1 (0), S1-4-, 2020
The Japanese Society of Toxicology
- Tweet
Details 詳細情報について
-
- CRID
- 1390848647545161088
-
- NII Article ID
- 130007898490
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed